ULRR
metadata only
Reporting of second-generation p-values, Bayes factors and fragility indices in trials enhances assessment of clinical importance beyond p-values: a meta-epidemiologic study
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Reporting of second-generation p-values, Bayes factors and fragility indices in trials enhances assessment of clinical importance beyond p-values: a meta-epidemiologic study.#362323
- Effect of Emphasizing Methodological Limitations of Primary Studies in a Systematic Review Summary: Findings from Two Randomized Controlled Trials#276853
- No evidence of cognitive or psychological impact after returning research Alzheimer disease biomarkers: A delayed-start, noninferiority, randomized clinical trial#321482
- Data Sheet 2_Effectiveness and safety of commercial Chinese polyherbal preparations combined with menopausal hormone therapy for perimenopausal symptoms: a network meta-analysis of randomized controlled trials.pdf#347342
- Data Sheet 1_Effectiveness and safety of commercial Chinese polyherbal preparations combined with menopausal hormone therapy for perimenopausal symptoms: a network meta-analysis of randomized controlled trials.pdf#347344
Record · ID 413323
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive